Home > News > SurgRx Secures $4.5 Million in Third Round Funding
March 11th, 2004
SurgRx Secures $4.5 Million in Third Round Funding
SurgRx, a developer of proprietary nanotechnology designed to control the delivery of electro surgical energy in surgical sealing instruments, announced today that it has received $4.5 million in C round funding from Prospect Ventures, a venture capital firm focused on investments in biomedical and healthcare innovation. This announcement follows on the heels of the Company's announcement last month that it received $5 million in second round financing from California Technology Ventures.
Harris & Harris Group Reports Financial Statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015
Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015
Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference February 17th, 2015
Iran 1st among Islamic Nations in Scientific Production, Nanotechnology February 16th, 2015